Inventor · disambiguated record
Susumu Muto
Also filed as: MUTO SUSUMU
15 granted patents·24 pending applications·123 citations·filing 2001–2022
91Inventor score
Files withINST MED MOLECULAR DESIGN INC15MUTO SUSUMU10ITAI AKIKO4INST OF MEDICAL MOLECULAR DESI2JITSUBO CO LTD2
Top patents by PatentIndex Score
39 records- 0192US8097759B2Inflammatory cytokine release inhibitorMUTO SUSUMU·Filed 2010·Granted Jan 17, 2012·38 cites·3 claims
- 0290US7700655B2Antiallergic agentsINST MED MOLECULAR DESIGN INC·Filed 2007·Granted Apr 20, 2010·14 cites·16 claims
- 0387US7626042B2O-substituted hydroxyaryl derivativesINST MED MOLECULAR DESIGN INC·Filed 2003·Granted Dec 1, 2009·27 cites·15 claims
- 0483US8263657B2Inhibitors against the production and release of inflammatory cytokinesMUTO SUSUMU·Filed 2001·Granted Sep 11, 2012·22 cites·10 claims
- 0580US7671058B2N-(3,4-disubstituted phenyl) salicylamide derivativesINST MED MOLECULAR DESIGN INC·Filed 2007·Granted Mar 2, 2010·13 cites·5 claims
- 0676US8097610B2Derivative having PPAR agonistic activityITAI AKIKO·Filed 2006·Granted Jan 17, 2012·5 cites·14 claims
- 0775US11098078B2Peptide synthesis methodJITSUBO CO LTD·Filed 2016·Granted Aug 24, 2021·1 cites·21 claims
- 0868US2008234233A1Medicament for treatment of neurodegenerative diseasesINST MED MOLECULAR DESIGN INC·Filed 2008·Application pending·0 cites
- 0965US7998992B2Oxazolidinone derivative having inhibitory activity on 11β-hydroxysteroid dehydrogenase type 1INST MED MOLECULAR DESIGN INC·Filed 2008·Granted Aug 16, 2011·0 cites·4 claims
- 1061US7598418B2Amide derivativesINST MED MOLECULAR DESIGN INC·Filed 2003·Granted Oct 6, 2009·1 cites·21 claims
- 1161US2009239868A1Inhibitor of pai-1 productionINST OF MEDICAL MOLECULAR DESI·Filed 2008·Application pending·0 cites
- 1260US2008090779A1Antiallergic agentsINST MED MOLECULAR DESIGN INC·Filed 2007·Application pending·0 cites
- 1360US2010113770A1O-substituted hydroxyaryl derivativesINST MED MOLECULAR DESIGN INC·Filed 2009·Application pending·0 cites
- 1459US2008318956A1Inflammatory cytokine release inhibitorINST MED MOLECULAR DESIGN INC·Filed 2007·Application pending·0 cites
- 1559US2009192122A2Inflammatory cytokine release inhibitorINST MED MOLECULAR DESIGN INC·Filed 2007·Application pending·0 cites
- 1656US2006035944A1Remedies for neurodegenerative diseasesMUTO SUSUMU·Filed 2003·Application pending·0 cites
- 1756US2008311074A1Inhibitors against activation of NF-kappaBINST OF MEDICAL MOLECULAR DESI·Filed 2008·Application pending·0 cites
- 1854US7547716B2Sulfonamide derivativesINST MED MOLECULAR DESIGN INC·Filed 2002·Granted Jun 16, 2009·2 cites·9 claims
- 1952US2024116924A1Method for producing imidazopyridine derivativeTAGCYX BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 2051US2006122243A1AntiallergicMUTO SUSUMU·Filed 2003·Application pending·0 cites
- 2151US2011294813A1Oxazolidinone derivative having inhibitory activity on 11beta-hydroxysteroid dehydrogenase type 1ITAI AKIKO·Filed 2011·Application pending·0 cites
- 2250US2006111409A1Medicament for treatment of diabetesMUTO SUSUMU·Filed 2003·Application pending·0 cites
- 2350US2024270809A1Oral glp receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 2450US2006014811A1Medicament for treatment of cancerMUTO SUSUMU·Filed 2003·Application pending·0 cites
- 2549US2024277853A1Medium-molecular-weight compound conjugate for improving pharmacokinetic profile of medium-molecular-weight compound and method of producing the sameTAGCYK BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 2648US8044236B2Carboxilic acid derivativesINST MED MOLECULAR DESIGN INC·Filed 2007·Granted Oct 25, 2011·0 cites·4 claims
- 2748US7884234B2N-phenyloxamide derivativesINST MED MOLECULAR DESIGN INC·Filed 2007·Granted Feb 8, 2011·0 cites·7 claims
- 2848US2006089395A1Nf-kb activation inhibitorsMUTO SUSUMU·Filed 2003·Application pending·0 cites
- 2947US11420997B2Peptide synthesis methodJITSUBO CO LTD·Filed 2019·Granted Aug 23, 2022·0 cites·18 claims
- 3047US2024182908A1Deoxyribonucleoside or deoxyribonucleotide having novel artificial base applicable to screening for dna aptamer, and nucleic acid containing the sameTAGCYX BIOTECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 3147US2010234363A1Heterocyclic derivative having inhibitory activity on type-i 11 data-hydroxysteroid dehydrogenaseINST MED MOLECULAR DESIGN INC·Filed 2008·Application pending·0 cites
- 3247US2007254956A1Medicament for Therapeutic and/or Preventive Treatment of Restenosis or Reocclusion After Vascular Recanalization OperationSHUDO KOICHI·Filed 2004·Application pending·0 cites
- 3346US2007042997A1Medicament for treatment of dermal pigmentationITAI AKIKO·Filed 2004·Application pending·0 cites
- 3445US8633245B2PAI-1 inhibitorYAMAGUCHI YOUICHI·Filed 2009·Granted Jan 21, 2014·0 cites·20 claims
- 3545US7411076B2Coumarin derivativeINST MED MOLECULAR DESIGN INC·Filed 2002·Granted Aug 12, 2008·0 cites·2 claims
- 3644US2006229324A1Quinazolin-4-one derivativesITAI AKIKO·Filed 2003·Application pending·0 cites
- 3742US2006100257A1Inhibitors against the activation of ap-1 and nfatMUTO SUSUMU·Filed 2003·Application pending·0 cites
- 3842US2006019958A1Immunity-related protein kinase inhibitorsMUTO SUSUMU·Filed 2003·Application pending·0 cites
- 3938US2007276011A1Plasminogen Activator Inhibitor-1 InhibitorMUTO SUSUMU·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Susumu Muto files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →